Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 29974 | 177 | 19.3 | 53% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
| 346 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//CAMPTOTHECIN | 36072 |
| 1654 | 2 | DISTAMYCIN//MINOR GROOVE BINDER//PYRROLE IMIDAZOLE POLYAMIDE | 6885 |
| 29974 | 1 | CI 958//ARYLMETHYLAMINOPROPANEDIOLS//SR271425 | 177 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CI 958 | authKW | 1035101 | 3% | 100% | 6 |
| 2 | ARYLMETHYLAMINOPROPANEDIOLS | authKW | 690067 | 2% | 100% | 4 |
| 3 | SR271425 | authKW | 690067 | 2% | 100% | 4 |
| 4 | THIOXANTHONE | authKW | 553943 | 10% | 19% | 17 |
| 5 | CRISNATOL | authKW | 388161 | 2% | 75% | 3 |
| 6 | BENZOTHIOPYRANOINDAZOLE ANALOGS | authKW | 345034 | 1% | 100% | 2 |
| 7 | HYDROXYTHIOXANTHONES | authKW | 345034 | 1% | 100% | 2 |
| 8 | THIOXANTHEN 9 ONE | authKW | 230021 | 1% | 67% | 2 |
| 9 | 10H 1BENZOTHIOPYRANO3 2 CPYRIDIN 10 ONE | authKW | 172517 | 1% | 100% | 1 |
| 10 | 2 METHYL 2 7 METHYL 7H BENZOCCARBAZOL 10 YLMETHYLAMINO 1 3 PROPANEDIOL | authKW | 172517 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Chemistry, Organic | 839 | 32% | 0% | 56 |
| 2 | Chemistry, Medicinal | 757 | 20% | 0% | 35 |
| 3 | Oncology | 407 | 26% | 0% | 46 |
| 4 | Pharmacology & Pharmacy | 281 | 25% | 0% | 44 |
| 5 | Crystallography | 93 | 7% | 0% | 12 |
| 6 | Chemistry, Multidisciplinary | 18 | 10% | 0% | 17 |
| 7 | Biochemical Research Methods | 5 | 3% | 0% | 5 |
| 8 | Chemistry, Analytical | 3 | 3% | 0% | 6 |
| 9 | Biophysics | 0 | 2% | 0% | 3 |
| 10 | Biochemistry & Molecular Biology | 0 | 6% | 0% | 10 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CIENCIAS QUIM QUIM MED FARM | 172517 | 1% | 100% | 1 |
| 2 | MIRCROCIRCULAT | 172517 | 1% | 100% | 1 |
| 3 | NI IRF | 172517 | 1% | 100% | 1 |
| 4 | NORDAN | 172517 | 1% | 100% | 1 |
| 5 | STERLING WINTHROP PHARMACEUT | 172515 | 1% | 50% | 2 |
| 6 | PHARMACOL MARINE | 115005 | 2% | 17% | 4 |
| 7 | GROSSMAN CANC | 57504 | 1% | 33% | 1 |
| 8 | URODIGESTIF | 57504 | 1% | 33% | 1 |
| 9 | ACCELERA | 43128 | 1% | 25% | 1 |
| 10 | LAUREL HIGHLANDS CANC PROGRAM | 43128 | 1% | 25% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | INVESTIGATIONAL NEW DRUGS | 8174 | 6% | 0% | 11 |
| 2 | JOURNAL OF HETEROCYCLIC CHEMISTRY | 3567 | 8% | 0% | 15 |
| 3 | SELECTIVE CANCER THERAPEUTICS | 2826 | 1% | 2% | 1 |
| 4 | ANTI-CANCER DRUG DESIGN | 2470 | 2% | 0% | 3 |
| 5 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1496 | 5% | 0% | 8 |
| 6 | LETTERS IN DRUG DESIGN & DISCOVERY | 1148 | 2% | 0% | 3 |
| 7 | HETEROCYCLES | 829 | 5% | 0% | 8 |
| 8 | JOURNAL OF MEDICINAL CHEMISTRY | 793 | 6% | 0% | 10 |
| 9 | JOURNAL OF INCLUSION PHENOMENA | 542 | 1% | 0% | 1 |
| 10 | ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE | 484 | 4% | 0% | 7 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | JAVAHERI, M , SHIRVANI, G , AMINI, M , SAEMIAN, N , SAADATJOO, N , (2016) PREPARATION OF 1-FLUORO-4-METHYL-9H-[CARBONYL-C-14]THIOXANTHEN-9-ONE AND AMINE DERIVATIVES.JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. VOL. 59. ISSUE 8. P. 322 -324 | 9 | 69% | 0 |
| 2 | BENI, AS , MONFARED, SM , (2013) DFT AND MP2 CALCULATIONS ON NEW SERIES OF HYDROXYTHIOXANTHONES.JOURNAL OF MOLECULAR STRUCTURE. VOL. 1039. ISSUE . P. 8-21 | 14 | 42% | 1 |
| 3 | PAIVA, AM , PINTO, MM , SOUSA, E , (2013) A CENTURY OF THIOXANTHONES: THROUGH SYNTHESIS AND BIOLOGICAL APPLICATIONS.CURRENT MEDICINAL CHEMISTRY. VOL. 20. ISSUE 19. P. 2438-2457 | 20 | 26% | 9 |
| 4 | LANSIAUX, A , CATY, A , DELIGNY, N , BAILLY, C , (2002) CL958.BULLETIN DU CANCER. VOL. 89. ISSUE 6. P. 575-578 | 12 | 57% | 0 |
| 5 | SHARGHI, H , BENI, ARS , (2007) ONE-POT SYNTHESIS OF NOVEL THIOXANTHONE CROWN ETHERS.ARKIVOC. VOL. . ISSUE . P. 1-7 | 11 | 52% | 4 |
| 6 | SHARGHI, H , BENI, ARS , (2004) A NOVEL AND EFFICIENT METHOD FOR THE SYNTHESIS OF NEW HYDROXYTHIOXANTHONE DERIVATIVES.SYNTHESIS-STUTTGART. VOL. . ISSUE 17. P. 2900 -2904 | 10 | 56% | 22 |
| 7 | SHARGHI, H , BENI, AS , (2008) SYNTHESIS AND NUCLEOPHILIC SUBSTITUTION REACTION OF 1-HALO-9H-THIOXANTHEN-9-ONE.JOURNAL OF THE IRANIAN CHEMICAL SOCIETY. VOL. 5. ISSUE . P. S33-S39 | 10 | 50% | 2 |
| 8 | ZINAD, DS , HUSSAIN, M , AKRAWI, OA , VILLINGER, A , LANGER, P , (2011) SITE-SELECTIVE SUZUKI-MIYAURA REACTIONS OF THE BIS(TRIFLATE) OF 1,3-DIHYDROXYTHIOXANTHONE.TETRAHEDRON LETTERS. VOL. 52. ISSUE 27. P. 3451 -3454 | 11 | 38% | 2 |
| 9 | GONCALVES, PH , HIGH, F , JUNIEWICZ, P , SHACKLETON, G , LI, J , BOERNER, S , LORUSSO, PM , (2008) PHASE I DOSE-ESCALATION STUDY OF THE THIOXANTHONE SR271425 ADMINISTERED INTRAVENOUSLY ONCE EVERY 3 WEEKS IN PATIENTS WITH ADVANCED MALIGNANCIES.INVESTIGATIONAL NEW DRUGS. VOL. 26. ISSUE 4. P. 347 -354 | 7 | 64% | 5 |
| 10 | CAMPONE, M , ISAMBERT, N , BOURBOULOUX, E , MAURY, S , MONIN-BAROILLE, P , BERILLE, J , FUMOLEAU, P , (2007) PHASE I DOSE-ESCALATION STUDY OF A NOVEL ANTITUMOR AGENT, SR271425, ADMINISTERED INTRAVENOUSLY IN SPLIT DOSES (D1-D2-D3) IN PATIENTS WITH REFRACTORY SOLID TUMORS.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 59. ISSUE 5. P. 689-695 | 4 | 100% | 4 |
Classes with closest relation at Level 1 |